Restoring the gut biome after antibiotics could lead to better outcomes for ovarian cancer patients

by Cleveland ClinicCredit: Pixabay/CC0 Public DomainAntibiotics routinely used in ovarian cancer care indiscriminately kill gut bacteria, leading to faster cancer progression and lower survival r

Updated on: January 30,2024

Restoring the gut biome after antibiotics could lead to better outcomes for ovarian cancer patients

by Cleveland ClinicCredit: Pixabay/CC0 Public DomainAntibiotics routinely used in ovarian cancer care indiscriminately kill gut bacteria, leading to faster cancer progression and lower survival r

Updated on:January 30,2024

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at

Updated on: April 01,2024

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at

Updated on:April 01,2024

New study addresses colorectal cancer disparities in Black communities

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA new University of Kentucky Markey Cancer Center study highlights the need for increased outreach and education to red

Updated on: January 13,2024

New study addresses colorectal cancer disparities in Black communities

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA new University of Kentucky Markey Cancer Center study highlights the need for increased outreach and education to red

Updated on:January 13,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on: January 15,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on:January 15,2024

Software improves the ability to pinpoint specific genetic mutations that drive cancer

by Colin Poitras,Yale UniversityCredit: Unsplash/CC0 Public DomainA new open-source software package calledcancereffectsizeRdeveloped by the Townsend Lab greatly improves the ability

Updated on: January 03,2024

Software improves the ability to pinpoint specific genetic mutations that drive cancer

by Colin Poitras,Yale UniversityCredit: Unsplash/CC0 Public DomainA new open-source software package calledcancereffectsizeRdeveloped by the Townsend Lab greatly improves the ability

Updated on:January 03,2024

A simple intervention benefits cancer patients while saving hospitals money, study shows

by University of PittsburghCredit: Unsplash/CC0 Public DomainCancer patients who received specialized mental health support as part of their treatment plan were more likely to see improvements in

Updated on: March 20,2024

A simple intervention benefits cancer patients while saving hospitals money, study shows

by University of PittsburghCredit: Unsplash/CC0 Public DomainCancer patients who received specialized mental health support as part of their treatment plan were more likely to see improvements in

Updated on:March 20,2024

Investigators build a better targeted drug therapy using the power of computation

by Brigham and Women's HospitalCancer cell during cell division. Credit: National Institutes of HealthAntibody drug conjugates (ADCs)—cancer drugs that are designed to target and destroy canc

Updated on: June 08,2024

Investigators build a better targeted drug therapy using the power of computation

by Brigham and Women's HospitalCancer cell during cell division. Credit: National Institutes of HealthAntibody drug conjugates (ADCs)—cancer drugs that are designed to target and destroy canc

Updated on:June 08,2024

Novel classification can lead to new ways to diagnose and treat cancer

by Baylor College of MedicineDr. Chad Creighton is the first author of this work. Credit: Baylor College of MedicineA novel approach to studying cancer has enabled researchers to group about 10,0

Updated on: March 01,2024

Novel classification can lead to new ways to diagnose and treat cancer

by Baylor College of MedicineDr. Chad Creighton is the first author of this work. Credit: Baylor College of MedicineA novel approach to studying cancer has enabled researchers to group about 10,0

Updated on:March 01,2024

Study reveals a trio of immune cells vital in response to liver cancer immunotherapy

by The Mount Sinai HospitalThe study revealed how certain immune cell interactions in tumors facilitate response to checkpoint blockade, pointing to potential new approaches to cancer immunothera

Updated on: February 23,2024

Study reveals a trio of immune cells vital in response to liver cancer immunotherapy

by The Mount Sinai HospitalThe study revealed how certain immune cell interactions in tumors facilitate response to checkpoint blockade, pointing to potential new approaches to cancer immunothera

Updated on:February 23,2024

Mathematical methods for diagnosing breast cancer

by Kaunas University of Technology100 microscope images of breast tissue were analyzed in order to teach computer to recognize malignancy; 85 percent accuracy rate was achieved. Credit: KTUA team

Updated on: April 14,2024

Mathematical methods for diagnosing breast cancer

by Kaunas University of Technology100 microscope images of breast tissue were analyzed in order to teach computer to recognize malignancy; 85 percent accuracy rate was achieved. Credit: KTUA team

Updated on:April 14,2024

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC

Updated on: May 17,2024

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC

Updated on:May 17,2024

Study refines understanding of T cells' action in HIV immune response

by Los Alamos National LaboratoryThe effect of M-T807R1 administration and RAL monotherapy on blood CD8+T cell dynamics. The effects of M-T807R1 on the dynamics of CD8 cells in individual m

Updated on: July 04,2024

Study refines understanding of T cells' action in HIV immune response

by Los Alamos National LaboratoryThe effect of M-T807R1 administration and RAL monotherapy on blood CD8+T cell dynamics. The effects of M-T807R1 on the dynamics of CD8 cells in individual m

Updated on:July 04,2024